4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tevogen Inc. (TVGN) operates in the Biotechnology industry and is headquartered in Warren, United States with about 18 employees. Its market capitalization is roughly $93 million. In the fiscal year ended 2025-12-31, TVGN reported $0M in revenue and ($26M) in net income.
Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($26M) | ($54M) | ($9M) | ($14M) | — |
| Net Income | ($26M) | ($14M) | ($60M) | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($6M) | ($5M) | ($5M) | ($6M) | ($5M) | — |
| Net Income | ($6M) | ($5M) | ($5M) | ($6M) | ($6M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $4M | $4M | $6M | $357M |
| Total Liabilities | $13M | $10M | $100M | $15M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TVGN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms